Concepedia
Statistics
Publications
18
Citations
2.8K
H-Index
17
Active since
2002
Affiliations
Hackensack University Medical Center(Current)
Columbia University Irving Medical Center
Washington University in St. Louis
The Ohio State University
Neurological Surgery
Samuel Goldlust is an author at Hackensack University Medical Center specializing in medicine, oncology, and brain tumors.
Publications per year
2002–2025
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations
Medicine, Oncology, Pharmacology +13
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Linda M. Liau, Keyoumars Ashkan, David D. Tran et al. · Journal of Translational Medicine · 2018 · 540 citations · Full text
Medicine, Immunology, Oncology +17
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
Linda M. Liau, Keyoumars Ashkan, Steven Brem et al. · JAMA Oncology · 2022 · 405 citations · Full text
A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma
Jiayi Huang, Rekha Chaudhary, Adam L. Cohen et al. · Journal of Neuro-Oncology · 2019 · 129 citations
Medicine, Oncology, Pharmacology +14
Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients
Herbert B. Newton, Samuel Goldlust, Dennis K. Pearl · Journal of Neuro-Oncology · 2006 · 114 citations
Medicine, Pharmacokinetics, Pharmacology +8
1–5 of 18